NCT00239577View on ClinicalTrials.gov

A Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

April 5, 2006

Primary Completion Date

June 19, 2007

Study Completion Date

June 19, 2007

Conditions
Dengue
Interventions
BIOLOGICAL

Live attenuated tetravalent dengue vaccine

Live attenuated tetravalent dengue vaccine

BIOLOGICAL

Placebo

Placebo

Trial Locations (1)

20910

GSK Investigational Site, Silver Spring

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY